Beta Drugs Limited (NSE:BETA)
India · Delayed Price · Currency is INR 1,423.40
-6.10 (-0.43%)
At close: Jun 1, 2026
Beta Drugs Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 29, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 14,369 | 12,005 | 19,235 | 11,861 | 6,027 | 5,437 | |
Market Cap Growth | -17.75% | -37.59% | 62.17% | 96.79% | 10.87% | 423.79% |
Enterprise Value | 14,598 | 12,237 | 19,147 | 11,782 | 6,023 | 5,446 |
Last Close Price | 1423.40 | 1189.30 | 1905.50 | 1175.00 | 597.10 | 538.57 |
PE Ratio | 34.78 | 28.94 | 45.35 | 32.55 | 19.62 | 21.90 |
PS Ratio | 3.73 | 3.12 | 5.31 | 4.01 | 2.65 | 2.96 |
PB Ratio | 5.87 | 4.91 | 9.76 | 7.55 | 4.91 | 5.89 |
P/TBV Ratio | 6.12 | 5.11 | 10.20 | 7.82 | 5.10 | 6.17 |
P/FCF Ratio | - | - | - | 61.41 | 116.57 | 53.30 |
P/OCF Ratio | 38.54 | 32.20 | 53.22 | 38.35 | 25.78 | 18.35 |
EV/Sales Ratio | 3.79 | 3.18 | 5.28 | 3.98 | 2.65 | 2.96 |
EV/EBITDA Ratio | 19.29 | 16.17 | 26.06 | 19.67 | 11.27 | 12.75 |
EV/EBIT Ratio | 24.94 | 20.91 | 30.84 | 23.50 | 14.00 | 15.37 |
EV/FCF Ratio | -90.14 | - | - | 61.00 | 116.49 | 53.39 |
Debt / Equity Ratio | 0.60 | 0.60 | 0.70 | 0.09 | 0.17 | 0.22 |
Debt / EBITDA Ratio | 1.95 | 1.95 | 1.88 | 0.25 | 0.38 | 0.48 |
Debt / FCF Ratio | - | - | - | 0.76 | 3.93 | 2.02 |
Net Debt / Equity Ratio | 0.09 | 0.09 | -0.05 | -0.09 | 0.01 | 0.04 |
Net Debt / EBITDA Ratio | 0.30 | 0.30 | -0.12 | -0.23 | 0.02 | 0.08 |
Net Debt / FCF Ratio | -1.42 | -1.42 | 12.56 | -0.72 | 0.23 | 0.32 |
Asset Turnover | 0.83 | 0.83 | 1.05 | 1.31 | 1.27 | 1.34 |
Inventory Turnover | 2.55 | 2.55 | 3.88 | 4.51 | 4.88 | 5.83 |
Quick Ratio | 2.26 | 2.26 | 2.54 | 1.42 | 1.43 | 1.42 |
Current Ratio | 3.10 | 3.10 | 3.22 | 2.10 | 2.03 | 1.98 |
Return on Equity (ROE) | 18.78% | 18.78% | 23.95% | 26.03% | 28.54% | 30.85% |
Return on Assets (ROA) | 7.85% | 7.85% | 11.24% | 13.85% | 15.10% | 16.09% |
Return on Invested Capital (ROIC) | 17.44% | 19.58% | 27.91% | 28.04% | 29.31% | 29.96% |
Return on Capital Employed (ROCE) | 15.10% | 15.10% | 18.60% | 29.60% | 31.80% | 32.60% |
Earnings Yield | 2.89% | 3.45% | 2.21% | 3.07% | 5.10% | 4.57% |
FCF Yield | -1.13% | -1.35% | -0.04% | 1.63% | 0.86% | 1.88% |
Buyback Yield / Dilution | -0.43% | -0.43% | -5.00% | 4.76% | - | - |